FDA Device recall Z-1841-2025
ABBOTT DIAGNOSTICS PROBE CONDITIONING F/ARCHITECT ANLYZ ABBDIA SOLUTION
- FDA Device
- Class II
- ongoing
- Published 2025-06-04
On 2025-06-04 the FDA classified a Class II recall of ABBOTT DIAGNOSTICS PROBE CONDITIONING F/ARCHITECT ANLYZ ABBDIA SOLUTION by Mckesson Medical Surgical Corporate Office, citing transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failu….
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1841-2025 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2025-04-24 |
| Published | 2025-06-04 |
| Last updated | 2026-09-13 11:57 UTC |
| Company | Mckesson Medical Surgical Corporate Office |
| Distribution | US |
Product
ABBOTT DIAGNOSTICS PROBE CONDITIONING F/ARCHITECT ANLYZ ABBDIA SOLUTION.
Reason
transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.
Identifiers
| code_info | Catalog No. 01L5640; GTIN: 380740001193; Order No. 46048552. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:57 UTC. Current status: ongoing.
Other recalls by Mckesson Medical Surgical Corporate Office
- Clearview Strep A Exact II Dipstick Respiratory Kit, CLIA Waived
FDA Device · Class II · 2025-08-27 · Mckesson Medical Surgical Corporate Office - PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513…
FDA Drug · Class II · 2025-07-30 · Mckesson Medical Surgical Corporate Office - BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK
FDA Drug · Class II · 2025-07-30 · Mckesson Medical Surgical Corporate Office - EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 9…
FDA Drug · Class II · 2025-07-30 · Mckesson Medical Surgical Corporate Office - BD MICROBIOLOGY FLUID THIOGLYCOLLATE MED TUBE 1004321196 (100/CT) MEDIA
FDA Device · Class II · 2025-06-04 · Mckesson Medical Surgical Corporate Office
All Mckesson Medical Surgical Corporate Office recalls
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1841-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.